# Surrozen share price today (Surrozen, Inc., SRZN)

> Surrozen, Inc.'s balance sheet is under water: its net worth is negative, so it owes more than it owns. The latest quarter's profit comes from a one-off item larger than a full quarter's revenue, not from the business. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. SRZN · Healthcare · Biotechnology · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/srzn

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $31.65 (+159.4% in a year)
- Revenue (Jun 2026): ₹0.0 B
- Profit (Jun 2026), incl. one-off: ₹0.0 B (one-off item, see below)
- ROE: 129%, FY25

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Surrozen share price today? Surrozen, Inc.'s share price was $31.65 at the close on 4 November 2026. That is 25.3% above its average price over the last 200 trading days. In the last 52 weeks it traded between $12 and $34, and at that close it sat 91% of the way up from that low. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 7 weeks in a row. Over the last 1 year the share price moved +263% while the S&P 500 moved +18%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Surrozen pay? Surrozen, Inc. pays no dividend. In the last 9 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Surrozen on? Surrozen is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Surrozen profitable? Surrozen, Inc. earned ₹0.0 B of net profit in the Jun 2026 quarter. That quarter includes a one-off gain bigger than its revenue, so the comparison with last year does not reflect normal business. The full FY25 year was a loss of ₹0.2 B. That is 640.8% of the quarter's revenue. The same quarter a year earlier earned ₹0.0 B. 7 of the last 9 reported quarters were loss-making. Jun 2026 profit was ₹0.0 B, +46.9% on a year earlier. Read this profit with care: at ₹0.0 B it is bigger than the quarter's whole revenue of ₹0.0 B. No business earns more than it takes in from sales, so this is a one-off item (for example a debt settlement, a tax write-back or an asset sale), not money the business earned. The underlying business is running at a −207.4% operating margin. The jump on last year, and any P/E built on this profit, come from the one-off, not from a real turn in earnings. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## How much revenue does Surrozen make, and is it growing? Surrozen, Inc. reported ₹0.0 B of revenue in the Jun 2026 quarter, +408.6% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 3 years it has grown −34.7% a year on average. The last full year, FY25, came in at ₹0.0 B. The last four reported quarters add to ₹0.0 B. FY25 revenue was ₹0.0 B, −67.4% on the year before. Recent pace: the last four quarters grew +176.9% on average, against −34.7% a year over the longer run, so this year is growing faster than its own long-run rate. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## How much of its sales does Surrozen keep? Surrozen, Inc.'s sales have fallen to very little: FY25 revenue was ₹0.0 B, against ₹0.0 B in FY22. On sales that small an operating margin is not a useful reading, so this section is left out until sales recover. ## Is Surrozen's profit turning into cash? Surrozen, Inc.'s cash-flow history is too short to judge how much of its profit turns into cash. In FY25 its operations used ₹0.0 B of cash, against −₹0.2 B of profit. After ₹0.0 B of spending on assets, free cash was ₹0.0 B: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: it spends almost nothing on new assets, so the cash goes on running the business. The next section shows the spending figures. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## Where does Surrozen's cash go? Surrozen, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent ₹0.0 B on assets over the last 3 years. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: ₹0.0 B over the last 3 years. In short: almost nothing is being spent on new assets, so the cash goes on running the business. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## What is Surrozen's P/E ratio, and how does it compare with its own history? Surrozen, Inc. has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. The P/E comes back here once profit turns positive. ## Is the Surrozen business getting better or worse? Surrozen, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 4 quarters of 0 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. The return-on-capital line is not shown: net worth is negative, so a return on capital means nothing. The balance sheet is in distress, and this reading uses the growth lines alone. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Surrozen earn on its capital? Surrozen, Inc. earned a ROE of 129% in FY25. That is up from a low of −47% in FY22. We cannot compare its return on capital used with its cost of capital from the data we have. ## Does Surrozen have too much debt? Surrozen, Inc.'s net worth is negative: it owes more than it owns, so a debt-to-equity ratio means nothing here. Year by year, that ratio went from 0.07 in FY21 to −0.04 in FY25. So the returns on this page come from the business, not from borrowed money. This company reports in its home currency, not US dollars, so the money charts are left out here. The figures in the text are in that currency (₹); nothing is converted. ## What is the Surrozen shareholding pattern? 31.6% of Surrozen, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 2.9 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Surrozen from balance-sheet trouble? For Surrozen, Inc., the Z-score is −7.10. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the danger zone. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of −7.10 is inside the danger zone, so the balance sheet is a real risk. ## How does Surrozen rank in its industry? There is no score against its industry: Surrozen, Inc. is not among the largest members shown in this industry comparison for Biotechnology. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Surrozen compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Surrozen in size? Surrozen is the 136th largest of 211 Biotechnology companies on Sector Alpha by market value (scores of 5 November 2026). Just above it: DBV Technologies S.A., Crescent Biopharma, Inc. and Aclaris Therapeutics, Inc. Just below it: Puma Biotechnology, Inc., Valneva SE and Ovid Therapeutics Inc. ### Biotechnology companies close in size

1. [DBV Technologies S.A.](https://www.sectoralpha.in/us/stocks/dbvt) $622 million
2. [Crescent Biopharma, Inc.](https://www.sectoralpha.in/us/stocks/cbio) $592 million
3. [Aclaris Therapeutics, Inc.](https://www.sectoralpha.in/us/stocks/acrs) $570 million
4. Surrozen, Inc. $554 million
5. [Puma Biotechnology, Inc.](https://www.sectoralpha.in/us/stocks/pbyi) $552 million
6. [Valneva SE](https://www.sectoralpha.in/us/stocks/valn) $539 million
7. [Ovid Therapeutics Inc.](https://www.sectoralpha.in/us/stocks/ovid) $535 million

[All 211 Biotechnology companies, largest first](https://www.sectoralpha.in/us/sectors/biotechnology#all-companies)

### Companies close in size in other industries

1. [Boost Run, Inc.](https://www.sectoralpha.in/us/stocks/brun) $528 million · Software - Infrastructure
2. [Puma Biotechnology, Inc.](https://www.sectoralpha.in/us/stocks/pbyi) $528 million · Biotechnology
3. Surrozen, Inc. $527 million
4. [Valneva SE](https://www.sectoralpha.in/us/stocks/valn) $526 million · Biotechnology
5. [Ennis, Inc.](https://www.sectoralpha.in/us/stocks/ebf) $525 million · Business Equipment & Supplies

## What else do people ask about Surrozen? ### What were Surrozen's latest quarterly results? Surrozen, Inc. reported revenue of ₹0.0 B and net profit of ₹0.0 B for the Jun 2026 quarter. Revenue rose 408.6% and profit rose 46.9% compared with a year earlier. The operating margin was −207.4%, 709.9 percentage points higher than a year earlier (as of 4 November 2026). ### What is Surrozen's market cap? Surrozen, Inc.'s market capitalisation is $554 M at a stock price of $31.65. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### Is Surrozen growing? Yes, Surrozen, Inc. is growing. In the latest quarter, revenue was +408.6% on a year earlier and profit +46.9%, and the margin moved +709.9 percentage points to −207.4%. Over the last four quarters, results have been improving (as of 4 November 2026). ### How is Surrozen performing? Surrozen, Inc.'s latest readings are below. In its latest quarter, revenue rose 408.6% and profit rose 46.9% compared with a year earlier. Over the past 13 weeks it has done better than the S&P 500, for 7 weeks running. This describes what the data did, not a rating (as of 4 November 2026). ### Will Surrozen's stock price go up? This page does not forecast Surrozen, Inc.'s stock price. What it shows instead: the stock price is $31.65. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026). ### What could break the Surrozen story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Surrozen a stock worth studying right now? What the numbers show: Surrozen, Inc.'s balance sheet is under water: its net worth is negative, so it owes more than it owns. The latest quarter's profit comes from a one-off item larger than a full quarter's revenue, not from the business. This is a high-risk situation: shareholders can be wiped out by new shares or a restructuring before the business recovers. The main open question: whether the business can earn its way back to positive net worth before new shares or a restructuring get there first. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.